Trifecta Capital Advisors LLC Buys 802 Shares of Intuitive Surgical, Inc. $ISRG

Trifecta Capital Advisors LLC lifted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.4% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 13,368 shares of the medical equipment provider’s stock after acquiring an additional 802 shares during the period. Intuitive Surgical makes up approximately 1.2% of Trifecta Capital Advisors LLC’s holdings, making the stock its 28th biggest holding. Trifecta Capital Advisors LLC’s holdings in Intuitive Surgical were worth $7,264,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of ISRG. Chilton Capital Management LLC lifted its holdings in Intuitive Surgical by 614.3% during the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 43 shares in the last quarter. Elite Financial Inc. acquired a new stake in shares of Intuitive Surgical during the first quarter worth about $26,000. LFA Lugano Financial Advisors SA acquired a new stake in shares of Intuitive Surgical during the first quarter worth about $30,000. TD Capital Management LLC boosted its holdings in shares of Intuitive Surgical by 300.0% in the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock valued at $30,000 after buying an additional 45 shares during the period. Finally, 1248 Management LLC bought a new stake in Intuitive Surgical in the 1st quarter valued at $30,000. Institutional investors own 83.64% of the company’s stock.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, insider Gary S. Guthart sold 29,360 shares of Intuitive Surgical stock in a transaction on Friday, August 29th. The shares were sold at an average price of $472.49, for a total value of $13,872,306.40. Following the sale, the insider directly owned 19,827 shares in the company, valued at approximately $9,368,059.23. The trade was a 59.69% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Amy L. Ladd sold 336 shares of the stock in a transaction that occurred on Wednesday, September 3rd. The shares were sold at an average price of $470.11, for a total value of $157,956.96. Following the transaction, the director directly owned 1,074 shares of the company’s stock, valued at approximately $504,898.14. The trade was a 23.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 45,224 shares of company stock valued at $21,716,492. 0.70% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of brokerages have recently issued reports on ISRG. Deutsche Bank Aktiengesellschaft reiterated a “sell” rating on shares of Intuitive Surgical in a research note on Friday, August 22nd. Piper Sandler reaffirmed an “overweight” rating and set a $595.00 target price (up previously from $575.00) on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. The Goldman Sachs Group decreased their price target on Intuitive Surgical from $621.00 to $567.00 and set a “buy” rating for the company in a research note on Wednesday, October 1st. UBS Group increased their price objective on shares of Intuitive Surgical from $547.00 to $585.00 and gave the stock a “neutral” rating in a research report on Wednesday, July 23rd. Finally, Wells Fargo & Company increased their target price on shares of Intuitive Surgical from $559.00 to $599.00 and gave the company an “overweight” rating in a report on Wednesday, July 23rd. Fourteen analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $589.43.

Intuitive Surgical Price Performance

NASDAQ:ISRG opened at $448.09 on Thursday. The company’s 50-day simple moving average is $460.50 and its 200 day simple moving average is $499.05. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00. The firm has a market capitalization of $160.63 billion, a P/E ratio of 62.50, a PEG ratio of 4.64 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, beating analysts’ consensus estimates of $1.93 by $0.26. The business had revenue of $2.44 billion during the quarter, compared to analyst estimates of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The company’s quarterly revenue was up 21.4% compared to the same quarter last year. During the same period in the previous year, the business earned $1.78 EPS. On average, equities research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.